Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 04, 2026, titled "Zydus announces Final Approval from the USFDA for Indocyanine Green for Injection with 180-Days CGT exclusivity".
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 04, 2026, titled "Zydus announces Final Approval from the USFDA for Indocyanine Green for Injection with 180-Days CGT exclusivity".